AU Patent

AU2007275294A1 — Human GLP-1 mimetibodies, compositions, methods and uses

Assigned to Janssen Biotech Inc · Expires 2008-01-24 · 18y expired

What this patent protects

Patent listed against Ozempic.

Drugs covered by this patent

Patent Metadata

Patent number
AU2007275294A1
Jurisdiction
AU
Classification
—
Expires
2008-01-24
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Biotech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.